Authors
Latest:
Sima Porten, MD, on gene-environment interactions in bladder cancer developmentSima P. Porten, MD, MPH, discusses the need to better understand how genetic makeup influences how individuals process environmental toxins.
Latest:
Episode 3 Video: Managing Overactive Bladder: From Dual Diagnoses to Geriatric ChallengesWayne Kuang, MD; and Matt T. Rosenberg, MD, discuss how overactive bladder presents with distinct pathophysiological mechanisms between genders, requires different diagnostic approaches when distinguishing from benign prostatic hyperplasia in men, impacts quality of life in older adults, benefits from early primary care intervention, and necessitates improved patient advocacy and educational initiatives for optimal management outcomes.
Latest:
Episode 2 Video: Identifying Patients with Intermediate Risk in NMIBCPanelists explore challenges in identification of intermediate risk patients and emphasize importance of risk stratification to improve outcomes in regards to NMIBC.
Latest:
Dr. Lara reviews the evolving systemic therapy paradigm in renal cell carcinoma“The question of who is a candidate for active surveillance is hard to answer because this is a bedside, gut decision," says Primo Nery Lara, Jr, MD.
Latest:
Chad Reichard, MD, on the Expanded Access Program for recombinant BCG"This certainly does feel like the beginning of the light at the end of the tunnel coming out of the BCG shortage," says Chad A. Reichard, MD.
Latest:
Special Report: Tips for PCPs on evaluating prostate cancer riskIn this video, part 4 of a 4-part series, panelists discuss how primary care providers can address patient questions on prostate cancer screening.
Latest:
Tips for optimizing productivity and collaboration for trainees who go unmatched in urology"Going into the upcoming application cycle, I am now a bit more excited and a little less terrified," writes Leah Ashton, MD.
Latest:
Current Unmet Needs in ccRCC DiagnosisImaging advancements in ccRCC are crucial for predicting tumor biology and enhancing treatment strategies through molecular imaging techniques.
Latest:
Leveraging technology to empower patients and reduce physician burnoutImplementing the right practice technology can not only mitigate physician burnout, it can also enable patients to take charge of their own care experience.
Latest:
Expert shares best practices for keeping a medical office cleanHere are 5 best practices for cleaning a medical office.
Latest:
Suzanne B. Merrill, MD, FACS, discusses rBCG and the NMIBC landscapeMerrill discusses the evolving non–muscle invasive bladder cancer treatment space.
Latest:
PARP inhibitors: Treating mCRPC from a genetic basisTreatments provide a targeted therapeutic strategy for metastatic castration-resistant prostate cancer.
Latest:
Artificial intelligence is the new ghost author in urological research“Although the future of AI within science is uncertain, disclosure of the use of AI is an excellent first step to balance academic integrity with disruptive innovation,” the authors write.
Latest:
Hailey Frye discusses improvement of pain management for nephrolithiasis“The benefit of being here at the University of Minnesota is that we have a bunch of different types of settings to be able to trial this," says Hailey Frye.
Latest:
Chad Ritenour, MD, on efforts to promote physician well-being at Emory Urology“One of the ways we make the most difference for our patients is we take care of the people who are taking care of them,” says Chad Ritenour, MD.
Latest:
Future Landscape of Prostate Cancer and Rectal SpacersThe expert panel concludes their discussion with a look toward the future of prostate cancer treatment and the evolving role of rectal spacers.
Latest:
Workplace violence in health care remains rampant as preventive efforts continueEven before the pandemic, violence against health care workers was escalating.
Latest:
Telehealth in urologic cancer: Lessons learned from the COVID-19 pandemic"The use of telemedicine is heavily dependent on supportive legislature," write Tracey L. Krupski, MD, and Jeunice Owens-Walton, MD.
Latest:
Bridget Koontz, MD, on PSMA-PET’s impact on treatment planning“For us, being able to know where the cancer is allows us to target it, and I think that lets us be much more effective with our treatment,” says Bridget F. Koontz, MD, FASTRO.
Latest:
Is video-based research feasible for pediatric urology visits?"This first paper was really to show that our research methodology was feasible and acceptable with pediatric urology patients and families. We've done that, and now we have a huge corpus of data that we can further analyze through empirical studies," says Francesca A. Williamson, PhD.
Latest:
FDA approves niraparib/abiraterone tablet for BRCA-positive mCRPCThe approval of the niraparib/abiraterone dual-action tablet for BRCA-positive mCRPC is based on findings from the phase 3 MAGNITUDE study.
Latest:
Real-World Outcomes With Nadofaragene in BCG-Unresponsive NMIBCPanelists discuss how real-world data from a recent Mayo Clinic study confirms the promising efficacy and favorable safety profile of nadofaragene firadenovec in BCG-unresponsive non–muscle-invasive bladder cancer (NMIBC), highlighting high cystectomy-free and overall survival rates, with longer follow-up needed to assess response durability.
Latest:
Better evidence for efficacy of postmenopausal incontinence treatments neededUrinary symptoms were not significantly improved from local estrogen use in most studies, though an improvement in vaginal symptoms was observed.
Latest:
Study shows proof of concept for sustained release with TAR-200“It's the sustained release and constant exposure to the gemcitabine that's most likely responsible for the high efficacy rates of that we're seeing with the TAR-200 system,” says Siamak Daneshmand, MD.
Latest:
Administering onabotA: Improving patient comfort and easing anxietyAn expert walks through specific actions that urologists and their teams can take before, during, and after the procedure.
Latest:
Preston Sprenkle, MD, highlights trial of TULSA vs radical prostatectomyThe trial has enrolled 201 patients with localized prostate cancer to date.
Latest:
Fluoroscopic Imaging and Other Developments in UrologyThe rationale for utilizing fluoroscopic imaging as well as other evolving technologies that are currently being developed and explored in urology.
Latest:
Urologic research and COVID-19: Unmasking the silver liningIn this column, the authors discuss how the coronavirus disease 2019 (COVID-19) shutdown yielded unexpected opportunities in urologic research.
Latest:
Emmanuel Chartier-Kastler, MD, shares initial data on UroActive System in women with SUI“Now, at 1 year, the 1-hour pad test has been done again, as it's part of the protocol, and she suffered 4 g of incontinence on this test, opposed to 125 g at the beginning,” says Emmanuel Chartier-Kastler, MD, PhD.
